Unsure About Your Measles Immunity? Here’s What to Know

As the United States contends with its largest measles outbreak in 35 years, a question is echoing through doctors’ offices and family group chats across the country: Am I still immune? According to NPR, the answer depends on when and how you were vaccinated — and for many adults, an additional shot may be the simplest path to certainty.

More than 4,000 measles cases have been reported nationwide in 2026, the highest annual total since 1991. Pennsylvania alone has confirmed 1,004 cases across 39 counties, along with 198 hospitalizations and five measles-associated deaths — making it the deadliest state outbreak on record this year, per the Pennsylvania Department of Health.

“It’s a very common question for people to ask, ‘am I immune? Am I OK? What do I need to do?’ And that is exactly the right question everyone should be asking themselves right now,” Patsy Stinchfield, executive director of the Measles Collaborative at the National Foundation for Infectious Diseases, told NPR.

Why This Outbreak Is Different

Measles is not an ordinary virus. It is more contagious than flu, polio, or Ebola, and it can linger in the air and on surfaces for up to two hours after an infected person has left a room. That efficiency helps explain how Pennsylvania’s outbreak escalated from roughly 12 cases in January to more than 100 new cases per week by early fall.

“If Pennsylvania can see it spread that fast, that can happen in any state that has low immunization rates,” Stinchfield warned. Dr. Adam Ratner, a pediatric infectious disease physician in New York City and author of “Booster Shots,” a history of measles, put it bluntly to NPR: “It’s more contagious than flu or polio or Ebola or any other scary-sounding disease you can think of.”

The outbreak has not stayed confined to one state. ABC News reported Pennsylvania’s cases surpassing 1,000, while New York Gov. Kathy Hochul declared a statewide disaster emergency as cases climbed in rural, under-immunized communities. Ohio has recorded 228 cases across 21 counties, a more than 400% increase over all of 2025, according to the Zanesville Times Recorder.

How to Know If You’re Protected

The public-health guidance is relatively straightforward, though it hinges on your personal vaccination history.

Born before 1957? You are presumed immune. Measles was so widespread in childhood before the vaccine era that near-universal infection was considered a rite of passage. As Dr. Larry Kociolek, a pediatric infectious disease specialist at Lurie Children’s Hospital of Chicago, told NPR: “It was thought that pretty much everyone in the U.S. was infected with measles as sort of a rite of passage in childhood.”

Vaccinated between 1963 and 1967? You may need an additional dose. During those years, some Americans received an early, inactivated (killed-virus) vaccine that proved less effective than later versions. The CDC advises talking with a doctor about whether one or two doses are appropriate.

Two documented doses of MMR? You are in good shape. Two doses of the measles, mumps, and rubella vaccine are 97% effective and confer lifelong immunity; a single dose is about 93% effective. The two-dose childhood schedule was adopted in 1989 after officials determined one dose was not enough to prevent outbreaks.

One dose, or an unclear history? Adults at higher risk — health care workers, college students, international travelers, and household contacts of immunocompromised people — are advised to have two doses.

The Case for Just Getting Another Shot

For people who cannot locate their records or who want reassurance without a blood draw, experts suggest a simpler route: get another dose. Antibody blood tests are imperfect and can produce false negatives, meaning a person may actually be protected yet still test negative.

“It’s possible that a person could actually be protected and test negative on one of those [antibody tests],” Dr. William Moss, a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health, told NPR. “I would say it is easier and less expensive to just get another MMR vaccine, and there is no harm in getting a second MMR vaccine or even a third, additional MMR dose.”

Kociolek echoed that assessment, noting there is “no harm” in an additional MMR vaccine and that adults in high-activity areas should consider a second dose. Most private insurance plans and Medicaid must cover an additional MMR vaccine at no cost to the patient.

A Preventable Crisis

The stakes are high because measles is far more than a rash. It can cause pneumonia and brain swelling, and roughly 20% of Pennsylvania’s identified cases required hospitalization. Death occurs in roughly one to three patients per 1,000 cases. Before vaccines were available, measles killed 400 to 500 people each year in the United States.

What makes the current wave especially concerning is who is getting sick. A large share of those infected this year have been unvaccinated adults, and people over 20 who lack immunity face a higher risk of serious complications. In Pennsylvania, only four of the state’s cases occurred among vaccinated individuals — less than 1%, a striking testament to how well the vaccine works.

The resurgence follows years of falling vaccination rates, driven in part by rising anti-vaccination sentiment during and after the COVID-19 pandemic. Federal vaccine policy has also shifted under Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine critic whose overhaul of agencies including the CDC’s Advisory Committee on Immunization Practices has drawn sharp criticism from public-health experts. One analysis in The Skeptic described the approach as “denialism as health policy.”

“The measles vaccine is safe. It’s highly effective, and it confers lifelong immunity,” Ratner told NPR — a message echoed by multiple specialists interviewed for the story.

What to Watch

The response to the outbreak is already accelerating in the hardest-hit states. Pennsylvania providers administered more than 53,000 MMR doses in September, roughly double the typical monthly volume. New York has sought federal CDC assistance as its case count climbed, and exposures have continued to surface on trains and at public events, as NPR reported in late September.

With vaccination now a live issue in the midterm elections, the coming weeks will test whether a renewed push to boost immunity can blunt the outbreak or whether the virus will find fresh footholds in communities where coverage remains thin. For now, the experts’ guidance is simple: if you’re unsure whether you’re protected, ask your doctor — or just roll up your sleeve.